These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1589132)

  • 1. [Sequential nimodipine-reduced glutathione treatment in alcoholic abstinence syndrome. Preliminary experience].
    Gatti A; Munari L; Perretti A; Porta M; Altamura C; Ragazzetti MG
    Minerva Med; 1992 May; 83(5):277-81. PubMed ID: 1589132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase.
    Brooks SP; Croft AP; Norman G; Shaw SG; Little HJ
    Neuroscience; 2008 Nov; 157(2):376-84. PubMed ID: 18835336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correction of the symptoms of late substance withdrawal syndrome by intra-conjunctival administration of 5% homatropine solution (preliminary report)].
    Stojek A; Madejski J; Dedelis E; Janicki K
    Psychiatr Pol; 1990; 24(3):195-201. PubMed ID: 2084727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine in human alcohol withdrawal syndrome--an open study.
    Altamura AC; Regazzetti MG; Porta M
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):37-40. PubMed ID: 2136211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat.
    Iimuro Y; Ikejima K; Rose ML; Bradford BU; Thurman RG
    Hepatology; 1996 Aug; 24(2):391-7. PubMed ID: 8690410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
    Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome.
    Solomon J; Rouck LA; Koepke HH
    Clin Ther; 1983; 6(1):52-8. PubMed ID: 6370437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of phenazepam on the nocturnal sleep of patients with the alcoholic abstinence syndrome].
    Danilin VP; Krylov EN; Magalif AIu; Raĭt ML
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):263-6. PubMed ID: 3984615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
    Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
    Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nimodipine in the medical treatment of Menière's disease: clinical experience.
    Lassen LF; Hirsch BE; Kamerer DB
    Am J Otol; 1996 Jul; 17(4):577-80. PubMed ID: 8841703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of dopamine neurotransmission on the development of ethanol dependence and course of abstinence syndrome].
    Samochowiec J
    Ann Acad Med Stetin; 1994; 40():195-217. PubMed ID: 7503446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic ethanol abuse related hospitalisation in the Internal Medicine Department of the Specialist Hospital in Biała Podlaska (Poland)].
    Chwaluk P
    Przegl Lek; 2004; 61(4):303-6. PubMed ID: 15521588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome.
    Miller WC; McCurdy L
    Clin Ther; 1984; 6(3):364-71. PubMed ID: 6722863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.
    Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lorazepam treatment for multiple ethanol withdrawals in mice.
    Becker HC; Veatch LM
    Alcohol Clin Exp Res; 2002 Mar; 26(3):371-80. PubMed ID: 11923591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acetyl-L-carnitine on ethanol consumption and alcohol abstinence syndrome in rats.
    Mangano NG; Clementi G; Costantino G; Calvani M; Matera M
    Drugs Exp Clin Res; 2000; 26(1):7-12. PubMed ID: 10761531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ethanol protocol to prevent alcohol withdrawal syndrome.
    Dissanaike S; Halldorsson A; Frezza EE; Griswold J
    J Am Coll Surg; 2006 Aug; 203(2):186-91. PubMed ID: 16864031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of nifedipine and chlordiazepoxide on alcohol withdrawal syndrome].
    Samochowiec J; Fabiańczyk K; Reszczyński R; Czopek I; Pełka-Wysiecka J; Horodnicki JM
    Psychiatr Pol; 1996; 30(2):307-20. PubMed ID: 8650291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients.
    Dolman JM; Hawkes ND
    Alcohol Alcohol; 2005; 40(6):515-9. PubMed ID: 16103035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.